Search results
9 lis 2017 · During the study period from 5 to 20 years, the absolute risk of distant recurrence among patients with T1N0 breast cancer was 10% for low-grade disease, 13% for moderate-grade disease,...
25 sty 2022 · Historically, only a minority of patients with metastatic breast cancer survived beyond 10 years . In recent times, expected survival has greatly improved, with data from the Surveillance, Epidemiology and End Results (SEER) suggest 5-year survival in the setting of metastatic disease to be 27% .
8 lis 2021 · We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between patient and tumor characteristics at primary diagnosis and late BCR up to 32 years after primary breast cancer diagnosis.
1 paź 2024 · Survival. Breast cancer survival varies widely by stage at diagnosis, molecular subtype, and other clinicopathologic features. Stage at diagnosis is the strongest prognostic indicator, with the 5-year relative survival rate ranging from >99% for localized stage disease to 87% for regional stage and 32% for distant stage disease.
26 lis 2020 · In cancer of the breast or prostate, cancer cells can remain dormant for years and even decades before recurring as metastatic disease. 23 During this latent period, patients are...
8 mar 2022 · The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis. J Natl Cancer Inst. 2022 Mar 8;114 (3):391-399. doi: 10.1093/jnci/djab202. Authors. Rikke Nørgaard Pedersen 1 , Buket Öztürk Esen 1 , Lene Mellemkjær 2 , Peer Christiansen 3 4 , Bent Ejlertsen 4 , Timothy Lee Lash 1 5 , Mette Nørgaard 1 , Deirdre Cronin-Fenton 1.
21 wrz 2022 · Our data from a population-based analysis showed a 10-year survival rates of 84% for patients with breast cancer diagnosis and they also confirmed the significant prognostic effect of subtype, revealing a better long-term prognosis for luminal A and luminal B patients and a lower survival for triple negative and luminal B/HER2 + patients.
